"Peptides, Cyclic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides whose amino and carboxy ends are linked together with a peptide bond forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS. Some of them are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL).
| Descriptor ID |
D010456
|
| MeSH Number(s) |
D04.345.566 D12.644.641
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptides, Cyclic".
Below are MeSH descriptors whose meaning is more specific than "Peptides, Cyclic".
This graph shows the total number of publications written about "Peptides, Cyclic" by people in this website by year, and whether "Peptides, Cyclic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peptides, Cyclic" by people in Profiles.
-
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ. Pituitary. 2019 Dec; 22(6):581-593.
-
An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity. Exp Neurol. 2011 Sep; 231(1):160-70.
-
Safety and efficacy of micafungin in transplantation recipients. Transplantation. 2006 Dec 15; 82(11):1549.
-
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. J Natl Cancer Inst. 2004 Oct 06; 96(19):1447-57.
-
Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14. Infect Immun. 2000 Mar; 68(3):1655-63.
-
Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci U S A. 1990 Sep; 87(17):6698-702.